Menu
Back to Journals » Psoriasis: Targets and Therapy » Volume 14
ISSN: 2230-326X
- View all (178)
- Volume 15, 2025 (22)
- Volume 14, 2024 (23)
- Volume 13, 2023 (7)
- Volume 12, 2022 (22)
- Volume 11, 2021 (14)
- Volume 10, 2020 (8)
- Volume 9, 2019 (13)
- Volume 8, 2018 (12)
- Volume 7, 2017 (9)
- Volume 6, 2016 (15)
- Volume 5, 2015 (13)
- Volume 4, 2014 (5)
- Volume 3, 2013 (4)
- Volume 2, 2012 (10)
- Volume 1, 2011 (1)
Archive: Volume 14, 2024
Research Progress on Glycolysis Mechanism of Psoriasis
Wei L, Zhang B, Tu Y, Liu A
Psoriasis: Targets and Therapy 2024, 14:195-206
Published Date: 31 December 2024
Unveiling Novel Protein Biomarkers for Psoriasis Through Integrated Analysis of Human Plasma Proteomics and Mendelian Randomization
Mao R, Zhang T, Yang Z, Li J
Psoriasis: Targets and Therapy 2024, 14:179-193
Published Date: 7 December 2024
Zinc Supplementation for Acrodermatitis Enteropathica Overlapped with Psoriasiform Lesions
Wang L, Zou S, Zhu Y
Psoriasis: Targets and Therapy 2024, 14:175-178
Published Date: 30 November 2024
The Association Between Patient-Reported Disease Burden and Treatment Switching in Patients with Plaque Psoriasis Treated with Nonbiologic Systemic Therapy
Patel V, Park SH, Zhong Y, Sima AP, Zhuo J, Roberts-Toler C, Becker B, Hovland S, Strober B
Psoriasis: Targets and Therapy 2024, 14:167-174
Published Date: 28 November 2024
Impact of IL-17A Inhibitors on Serum Uric Acid Levels in Psoriatic Patients with Hyperuricemia: A Prospective Observational Study
Wu C, He C, Wang H, Wang W, Jin H
Psoriasis: Targets and Therapy 2024, 14:153-166
Published Date: 25 November 2024
Impact of GLP-1 Receptor Agonists on Psoriasis and Cardiovascular Comorbidities: A Narrative Review
Haran K, Johnson CE, Smith P, Venable Z, Kranyak A, Bhutani T, Jeon C, Liao W
Psoriasis: Targets and Therapy 2024, 14:143-152
Published Date: 15 November 2024
A New Prescription Emollient Device (PED) For Psoriasis of Sensitive Areas and Folds: A Randomized Prospective Open Trial
Dall’Oglio F, Verzì AE, Guglielmi G, Zappulla S, Micali G
Psoriasis: Targets and Therapy 2024, 14:135-142
Published Date: 15 November 2024
Psoriasis Flare Following Paramyxovirus Infection
Di Lernia V, Bertoli C
Psoriasis: Targets and Therapy 2024, 14:131-134
Published Date: 6 November 2024
Metabolic Syndrome in Psoriasis and Psoriatic Arthritis in a Mixed Race Population: Comparison of Their Prevalences
Acioly PMG, Mazzillo MDLT, Machado CJ, Camargo C, Penetra MA, Januário V, Reis BRD, Ramos-e-Silva M, Carneiro S
Psoriasis: Targets and Therapy 2024, 14:123-130
Published Date: 31 October 2024
Do NSAIDs Trigger or Exacerbate Psoriasis? [Response to Letter]
Balak DMW, Hajdarbegovic E
Psoriasis: Targets and Therapy 2024, 14:121-122
Published Date: 5 October 2024
Secukinumab Causing Medication-Related Osteonecrosis of the Jaw, in a Patient Diagnosed with Psoriasis and Rheumatoid Arthritis
Hauer L, Moztarzadeh O, Baghalipour N, Gencur J
Psoriasis: Targets and Therapy 2024, 14:115-120
Published Date: 23 September 2024
Tobacco Smoking Interacted with Alcohol Drinking Could Increase the Failure of PASI75 Achievement at Week 8 Among Patients with Psoriasis: Findings Based on a Psoriasis Cohort
Shen F, Song Y, Qiang Y, Gao X, Li S, Zhang R, Gao Z, Li B, Jiang W, Wang R
Psoriasis: Targets and Therapy 2024, 14:103-114
Published Date: 23 September 2024
NSAIDs: Unveiling Their Role in Drug-Induced Psoriasis [Letter]
Shaikh S
Psoriasis: Targets and Therapy 2024, 14:101-102
Published Date: 13 September 2024
Adapting the Goeckerman Regimen for Psoriasis Treatment in Kenya: A Case Study of Successful Management in a Resource-Limited Setting
Smith P, Kranyak A, Johnson CE, Haran K, Muraguri Snr I, Maurer T, Bhutani T, Liao W, Kiprono S
Psoriasis: Targets and Therapy 2024, 14:93-100
Published Date: 29 August 2024
Commercial Diagnostics and Emerging Precision Medicine Technologies in Psoriasis and Atopic Dermatitis
Haran K, Kranyak A, Johnson CE, Smith P, Farberg AS, Bhutani T, Liao W
Psoriasis: Targets and Therapy 2024, 14:87-92
Published Date: 5 August 2024
Effectiveness and Drug Survival of Ixekizumab and Secukinumab in Patients with Moderate to Severe Plaque Psoriasis: Real-World Data from Bucharest, Romania
Bucur S, Serban ED, Ileanu BV, Costache RS, Nicolescu AC, Constantin T, Costache DO, Constantin MM
Psoriasis: Targets and Therapy 2024, 14:79-86
Published Date: 25 June 2024
Burden of Herpes Zoster Among Patients with Psoriatic Arthritis in the United States
Singer D, Thompson-Leduc P, Ma S, Gupta D, Cheng WY, Sendhil SR, Sundar M, Hagopian E, Stempniewicz N, Duh MS, Poston S
Psoriasis: Targets and Therapy 2024, 14:63-78
Published Date: 22 June 2024
The Perspective of Cannabidiol in Psoriasis Therapy
Stanescu AMA, Bejan GC, Balta MD, Andronic O, Toma C, Busnatu S
Psoriasis: Targets and Therapy 2024, 14:51-61
Published Date: 19 June 2024
Risk Factors for Psoriasis Flares: A Narrative Review
Potestio L, Lauletta G, Tommasino N, Portarapillo A, Salsano A, Battista T, Martora F, Megna M
Psoriasis: Targets and Therapy 2024, 14:39-50
Published Date: 30 May 2024
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries
Valencia López MJ, Stephan B, Meineke A, Wolf S, Thaci D, Mrowietz U, Andrees V, Rustenbach SJ, Reich K, Thalmann L, Bogena H, Staubach P, von Kiedrowski RM, Augustin M
Psoriasis: Targets and Therapy 2024, 14:29-38
Published Date: 14 May 2024
Therapeutic Potential of Spesolimab-Sbzo in the Management of Generalized Pustular Psoriasis Flares in Adults: Evidence to Date
Rega F, Trovato F, Bortone G, Pellacani G, Richetta AG, Dattola A
Psoriasis: Targets and Therapy 2024, 14:23-27
Published Date: 15 March 2024
Experiences of Dermatologists and Patients Regarding Psoriasis and Its Connection to Psoriatic Arthritis in Saudi Arabia
Fatani MI, Al-homood I, Bedaiwi M, Al Natour S, Erdogan A, Alsharafi A, Attar SM
Psoriasis: Targets and Therapy 2024, 14:11-22
Published Date: 18 January 2024
The Effects of Cardiometabolic Comorbidities on Biologic Treatment for Psoriasis with Respect to PASI Scores: A Qualitative Systematic Review
Osman A, Nigro A, Taylor AC, Saal R, Ormaza Vera A, Enos C
Psoriasis: Targets and Therapy 2024, 14:1-10
Published Date: 10 January 2024